Table I.
Association between the microRNA-101 expression and clinicopathologic characteristics in bladder cancer.
| Variables | Total (n=65) | Low expression (n=32) | High expression (n=33) | P-value |
|---|---|---|---|---|
| Sex | 0.434 | |||
| Male | 44 | 20 | 24 | |
| Female | 21 | 12 | 9 | |
| Age (years) | 0.450 | |||
| ≤60 | 39 | 21 | 18 | |
| >60 | 26 | 11 | 15 | |
| Tumor size (cm) | 0.325 | |||
| ≤3 | 33 | 14 | 19 | |
| >3 | 32 | 18 | 14 | |
| Grade | 0.150 | |||
| Well and moderately | 50 | 22 | 28 | |
| Poor | 15 | 10 | 5 | |
| Clinical T stage | 0.012 | |||
| Ta+Tis+T1 | 27 | 8 | 19 | |
| T2-T4 | 38 | 24 | 14 | |
| Lymph node metastasis | 0.018 | |||
| Present | 21 | 15 | 6 | |
| Absent | 44 | 17 | 27 | |
| Distant metastasis | 0.053 | |||
| Present | 4 | 4 | 0 | |
| Absent | 61 | 28 | 33 |
Data are presented as n. miR, microRNA.